Annual Report 2002–03

金耀基校長 （左） 與醫院管理局主 席梁智鴻醫生 （右） 主持確進糖尿 及内分泌專科中心的開幕禮 Prof. Ambrose King (left), vice- chancellor of the University, and Dr. C.H. Leong (right), chairman of the Hospital Authority, officiating at the opening ceremony of the Qualigenics Centre for Diabetes and Endocrine Disorders 3. Qualigenics Centre for Diabetes and Endocrine Disorders The Qualigenics Centre for Diabetes and Endocrine Disorders is a medical specialist clinic devoted to the total medical management of diabetes and endocrine diseases. It is a joint undertaking of GenRx Healthcare Ltd. (a subsidiary of HKR International Ltd.) and the University, with active participation by experts from the Division of Diabetes and Endocrinology of the Department of Medicine and Therapeutics. Wi th the opening of the Qualigenics Centre for Diabetes and Endocrine Disorders, private patients are given the choice of receiving total medical care for diabetes and endocrine diseases provided by the medical and nursing team of the division. Currently, Qualigenics runs two clinics. The first clinic is located at the School of Public Health Building at the Prince of Wales Hospital. The second clinic is located at Pier 3, Central, Hong Kong. 4. A Proprietary Production Method for Extracting the Active Ingredient in Yunzhi Yunzhi has long been used by the Chinese to enhance the immune system. As proven by scientific research, the most recognized active ingredient in Yunzhi is polysaccharide, which cannot be effectively absorbed by the human intestine. Research conducted by Prof. Albert Chow and his Ph.D. student Dr. Kevin Chu of the School of Pharmacy has led to the discovery of absorbable peptidoglucan (APG), a novel active ingredient in Yunzhi that can be readily absorbed by the human intestine and is effective in stimulating the immune system. Prof. Chow also developed a proprietary extraction method to enable APG to be retained in large quantities in the Yunzhi extract. The 3 .確進糖尿及內分泌專科中心 確進糖尿及內分泌專科中心是一所專科醫療中 心，為糖尿病及內分泌疾病病人提供全面的醫 療保健服務。確進是健力醫療（香港興業國際 集團成員）與香港中文大學合作的健康關注機 構，並獲中文大學內科及藥物治療學系同人積 極支持。該中心為社會大眾提供另一渠道，享 用中大糖尿病及內分泌疾病醫護隊伍的服務； 現設有兩個醫療站，分別位於沙田威爾斯親王 醫院公共衛生學院大樓和中環三號碼頭。 4 .提取雲芝有效成分的獨特技術 雲芝一直被認為可提高人體免疫系統的功能。 經科學證明，這種作用是由於雲芝的多糖體所 致。可是，多糖體卻不能直接被人體的腸道吸 收。藥劑學院周喜林敎授及其博士硏究生朱家 榮博士的硏究發現，雲芝還含有可吸收肽葡聚 糖（ APG )。APG 同樣具有提高人體免疫系統 功能的作用，而且容易被人體吸收。周敎授更 開發了一套獨特的提取技術，令 A P G 能大量 存留於雲芝提取物中。該技術的專營權已授予 本地一家健康食品生產公司，而朱家榮博士亦 受聘為該公司的硏究部經理。利用該提取技術 生產的「安固生」已於市場發售。 研究 Research 51